Innovation Reimagined

Our website is under development.

At Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.

Drug R&D + Therapeutic Solutions led by world-class scientists.

We specialize in advancing drugs for large areas of unmet medical need, maximizing the gap between expense and market opportunity. Some may call it brilliant; we call it innovation reimagined.

Solving unmet medical needs

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Unmet Needs
From Type 1 diabetes to Parkinsons, we are trying to change millions of lives.
Accelerated Pathways
Phase 2-ready drugs with strong safety and tolerability profiles.

Real solutions for real issues

At Adhera, we pride ourselves on identifying new uses for existing drugs and drug candidates, lowering risk while saving millions of dollars and years in development.

Diabetes

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Parkinsons

With 2 Phase-2 drugs in accelerated pathways, 4 large addressable markets of unmet needs, Adhera seeks to outstand in the biomedical market.

Product
Indication
Pre-clinical
Phase 1
Phase 2
Phase 3
MLR-1019
armesocarb

Parkinsons Disease

MLR-1023
Tolimidone

Type 1 Diabetes

Send us a message

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Contact Information

General Inquiries
info@adhera.com
Investor Relations
investors@adhera.com
Headquarters
Phone Number
(919) 518-3748